Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward V Loftus

Showing results (231-240 of 471) with videos related to

Pageof 48
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 14, 2011
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trialRemo Panaccione, Edward V Loftus, David Binion, et al.
Inflammatory Bowel Diseases|April 30, 2002
Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusionDouglas L Riegert-Johnson, John A Godfrey, Jeffrey L Myers, et al.
The Journal of Rheumatology|September 18, 2012
Incidence of spondyloarthropathy in patients with Crohn's disease: a population-based studyRaina Shivashankar, Edward V Loftus, William J Tremaine, et al.
Journal of Pediatric Surgery|February 19, 2019
Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patientsAmy L Lightner, Nicholas P McKenna, Ahmad Alsughayer, et al.
Gastroenterology|November 21, 2024
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative ColitisSiddharth Singh, Edward V Loftus, Berkeley N Limketkai, et al.
Journal of Crohn'S & Colitis|June 9, 2021
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative ColitisSubrata Ghosh, Yuri Sanchez Gonzalez, Wen Zhou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2016
Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's DiseaseSiddharth Singh, Herbert C Heien, Lindsey R Sangaralingham, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2014
Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirusAndrea Jones, Jeffrey D McCurdy, Edward V Loftus, et al.
Inflammatory Bowel Diseases|October 23, 2018
Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based CohortSang Hyoung Park, Satimai Aniwan, W Scott Harmsen, et al.
Inflammatory Bowel Diseases|March 17, 2017
Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative ColitisAmy L Lightner, Kellie L Mathis, Eric J Dozois, et al.
Pageof 48

Showing results (231-240 of 471) with videos related to

Sort By:
Pageof 48
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 14, 2011
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trialRemo Panaccione, Edward V Loftus, David Binion, et al.
Inflammatory Bowel Diseases|April 30, 2002
Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusionDouglas L Riegert-Johnson, John A Godfrey, Jeffrey L Myers, et al.
The Journal of Rheumatology|September 18, 2012
Incidence of spondyloarthropathy in patients with Crohn's disease: a population-based studyRaina Shivashankar, Edward V Loftus, William J Tremaine, et al.
Journal of Pediatric Surgery|February 19, 2019
Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patientsAmy L Lightner, Nicholas P McKenna, Ahmad Alsughayer, et al.
Gastroenterology|November 21, 2024
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative ColitisSiddharth Singh, Edward V Loftus, Berkeley N Limketkai, et al.
Journal of Crohn'S & Colitis|June 9, 2021
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative ColitisSubrata Ghosh, Yuri Sanchez Gonzalez, Wen Zhou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2016
Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's DiseaseSiddharth Singh, Herbert C Heien, Lindsey R Sangaralingham, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2014
Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirusAndrea Jones, Jeffrey D McCurdy, Edward V Loftus, et al.
Inflammatory Bowel Diseases|October 23, 2018
Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based CohortSang Hyoung Park, Satimai Aniwan, W Scott Harmsen, et al.
Inflammatory Bowel Diseases|March 17, 2017
Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative ColitisAmy L Lightner, Kellie L Mathis, Eric J Dozois, et al.
Pageof 48